Ixazomib [MLN2238] Pack Size:1 mg Prevents neurodegenerative processes in pathologies

Prevents neurodegenerative processes in pathologies such as Alzheimer's and Parkinson's disease

i) culture media to increase the stability and solubility of expressed proteins

nuclear contamination is virtually eliminated

highlighting its significance beyond embryonic development

1417 (2020)

Ixazomib [MLN2238] Pack Size:1 mg Prevents neurodegenerative processes in pathologiesPotent selective and reversible proteasome inhibitor (all proteolytic subunits). Targets the chymotrypsin like 5 subunit of the constitutive 20S proteasome (IC50=3. 4nM). Cross reacts and inhibits the trypsin like 2 subunit (IC50=3. 5M) and the caspase like peptidyl glutamyl peptide hydrolyzing (PGPH) 1 subunit (IC50=0. 03M). Anticancer compound effective in cell based assays, in xenografts and against multiple myeloma in vivo. In vitro, induces cell